Proof of concept studies for tissue-protective agents in multiple sclerosis
- Author
- MEHTA, L. R1 ; SCHWID, S. R1 ; GOELZ, S9 ; INGLESE, M10 ; KAPOOR, R11 ; KAPPOS, L12 ; KREITMAN, R13 ; LUBLIN, F. D14 ; MANN, A8 ; MARRIE, R. A15 ; O'LOONEY, P16 ; POLMAN, C. H17 ; ARNOLD, D. L2 ; RAVINA, B. M1 ; REINGOLD, S. C18 ; RICHERT, J. R16 ; SANDROCK, A. W9 ; WAUBANT, E19 ; CUTTER, G. R3 ; ARADHYE, S4 ; BALCER, L. J5 ; CALABRESI, P. A6 ; COHEN, J. A7 ; COLE, P. E8 ; GLANZMAN, R4
[1] University of Rochester Department of Neurology, Rochester, NY, United States
[2] Montreal Neurological Institute, Montreal, QC, United States
[3] University of Alabama-Birmingham, Department of Biostatistics, Birmingham, AL, United States
[4] Novartis Pharmaceuticals
[5] University of Pennsylvania Department of Neurology and Epidemiology, Philadelphia, PA, United States
[6] Johns Hopkins University Department of Neurology, Baltimore, MD, United States
[7] Cleveland Clinic, Cleveland, OH, United States
[8] Eisai Medical Research, Inc, United States
[9] Biogen Idec, Inc, United States
[10] New York University Department of Radiology and Neurology, New York, NY, United States
[11] National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom
[12] University Hospital, Basel, Switzerland
[13] Teva Pharmaceutical Industries, Ltd, United States
[14] Mount Sinai School of Medicine, New York, NY, United States
[15] University of Manitoba, Winnipeg, MB, Canada
[16] National Multiple Sclerosis Society, New York, NY, United States
[17] Vrije Universiteit Medical Center, Amsterdam, Netherlands
[18] Scientific and Clinical Review Associates, LLC, New York, NY, United States
[19] University of California ― San Francisco, Department of Neurology, San Francisco, CA, United States - Source
Multiple sclerosis. 2009, Vol 15, Num 5, pp 542-546, 5 p ; ref : 15 ref
- Publisher
- Sage Publications, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- clinical trial designs multiple sclerosis outcome measurement tissue protection
- Keyword (fr)
- Maladie dégénérative Pathologie du système nerveux Prévention Sclérose en plaques Maladie inflammatoire Pathologie du système nerveux central
- Keyword (en)
- Degenerative disease Nervous system diseases Prevention Multiple sclerosis Inflammatory disease Central nervous system disease
- Keyword (es)
- Enfermedad degenerativa Sistema nervioso patología Prevención Esclerosis en placa Enfermedad inflamatoria Sistema nervosio central patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17F Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17G Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
- Discipline
- Neurology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21566930
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1177/1352458508101939 
https://dx.doi.org/10.1177/1352458508101939
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/1352458508101939\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Proof of concept studies for tissue-protective agents in multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:18:\"Multiple sclerosis\";s:9:\"\u0000*\u0000stitle\";s:11:\"Mult. scler\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"542\";s:8:\"\u0000*\u0000epage\";s:3:\"546\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1352-4585\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:24:{i:0;s:12:\"SCHWID, S. R\";i:1;s:8:\"GOELZ, S\";i:2;s:10:\"INGLESE, M\";i:3;s:9:\"KAPOOR, R\";i:4;s:9:\"KAPPOS, L\";i:5;s:11:\"KREITMAN, R\";i:6;s:12:\"LUBLIN, F. D\";i:7;s:7:\"MANN, A\";i:8;s:12:\"MARRIE, R. A\";i:9;s:11:\"O'LOONEY, P\";i:10;s:12:\"POLMAN, C. H\";i:11;s:12:\"ARNOLD, D. L\";i:12;s:12:\"RAVINA, B. M\";i:13;s:14:\"REINGOLD, S. C\";i:14;s:13:\"RICHERT, J. R\";i:15;s:14:\"SANDROCK, A. W\";i:16;s:10:\"WAUBANT, E\";i:17;s:12:\"CUTTER, G. R\";i:18;s:10:\"ARADHYE, S\";i:19;s:12:\"BALCER, L. J\";i:20;s:15:\"CALABRESI, P. A\";i:21;s:11:\"COHEN, J. A\";i:22;s:10:\"COLE, P. E\";i:23;s:11:\"GLANZMAN, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Proof of concept studies for tissue-protective agents in multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Sage Publications\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/1352458508101939\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Proof of concept studies for tissue-protective agents in multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:18:\"Multiple sclerosis\";s:9:\"\u0000*\u0000stitle\";s:11:\"Mult. scler\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"542\";s:8:\"\u0000*\u0000epage\";s:3:\"546\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1352-4585\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:24:{i:0;s:12:\"SCHWID, S. R\";i:1;s:8:\"GOELZ, S\";i:2;s:10:\"INGLESE, M\";i:3;s:9:\"KAPOOR, R\";i:4;s:9:\"KAPPOS, L\";i:5;s:11:\"KREITMAN, R\";i:6;s:12:\"LUBLIN, F. D\";i:7;s:7:\"MANN, A\";i:8;s:12:\"MARRIE, R. A\";i:9;s:11:\"O'LOONEY, P\";i:10;s:12:\"POLMAN, C. H\";i:11;s:12:\"ARNOLD, D. L\";i:12;s:12:\"RAVINA, B. M\";i:13;s:14:\"REINGOLD, S. C\";i:14;s:13:\"RICHERT, J. R\";i:15;s:14:\"SANDROCK, A. W\";i:16;s:10:\"WAUBANT, E\";i:17;s:12:\"CUTTER, G. R\";i:18;s:10:\"ARADHYE, S\";i:19;s:12:\"BALCER, L. J\";i:20;s:15:\"CALABRESI, P. A\";i:21;s:11:\"COHEN, J. A\";i:22;s:10:\"COLE, P. E\";i:23;s:11:\"GLANZMAN, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Proof of concept studies for tissue-protective agents in multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Sage Publications\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/1352458508101939\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/1352458508101939\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Proof of concept studies for tissue-protective agents in multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:18:\"Multiple sclerosis\";s:9:\"\u0000*\u0000stitle\";s:11:\"Mult. scler\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"542\";s:8:\"\u0000*\u0000epage\";s:3:\"546\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1352-4585\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:24:{i:0;s:12:\"SCHWID, S. R\";i:1;s:8:\"GOELZ, S\";i:2;s:10:\"INGLESE, M\";i:3;s:9:\"KAPOOR, R\";i:4;s:9:\"KAPPOS, L\";i:5;s:11:\"KREITMAN, R\";i:6;s:12:\"LUBLIN, F. D\";i:7;s:7:\"MANN, A\";i:8;s:12:\"MARRIE, R. A\";i:9;s:11:\"O'LOONEY, P\";i:10;s:12:\"POLMAN, C. H\";i:11;s:12:\"ARNOLD, D. L\";i:12;s:12:\"RAVINA, B. M\";i:13;s:14:\"REINGOLD, S. C\";i:14;s:13:\"RICHERT, J. R\";i:15;s:14:\"SANDROCK, A. W\";i:16;s:10:\"WAUBANT, E\";i:17;s:12:\"CUTTER, G. R\";i:18;s:10:\"ARADHYE, S\";i:19;s:12:\"BALCER, L. J\";i:20;s:15:\"CALABRESI, P. A\";i:21;s:11:\"COHEN, J. A\";i:22;s:10:\"COLE, P. E\";i:23;s:11:\"GLANZMAN, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Proof of concept studies for tissue-protective agents in multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Sage Publications\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/1352458508101939\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Proof of concept studies for tissue-protective agents in multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:18:\"Multiple sclerosis\";s:9:\"\u0000*\u0000stitle\";s:11:\"Mult. scler\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"542\";s:8:\"\u0000*\u0000epage\";s:3:\"546\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1352-4585\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:24:{i:0;s:12:\"SCHWID, S. R\";i:1;s:8:\"GOELZ, S\";i:2;s:10:\"INGLESE, M\";i:3;s:9:\"KAPOOR, R\";i:4;s:9:\"KAPPOS, L\";i:5;s:11:\"KREITMAN, R\";i:6;s:12:\"LUBLIN, F. D\";i:7;s:7:\"MANN, A\";i:8;s:12:\"MARRIE, R. A\";i:9;s:11:\"O'LOONEY, P\";i:10;s:12:\"POLMAN, C. H\";i:11;s:12:\"ARNOLD, D. L\";i:12;s:12:\"RAVINA, B. M\";i:13;s:14:\"REINGOLD, S. C\";i:14;s:13:\"RICHERT, J. R\";i:15;s:14:\"SANDROCK, A. W\";i:16;s:10:\"WAUBANT, E\";i:17;s:12:\"CUTTER, G. R\";i:18;s:10:\"ARADHYE, S\";i:19;s:12:\"BALCER, L. J\";i:20;s:15:\"CALABRESI, P. A\";i:21;s:11:\"COHEN, J. A\";i:22;s:10:\"COLE, P. E\";i:23;s:11:\"GLANZMAN, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Proof of concept studies for tissue-protective agents in multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Sage Publications\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/1352458508101939\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Proof of concept studies for tissue-protective agents in multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:18:\"Multiple sclerosis\";s:9:\"\u0000*\u0000stitle\";s:11:\"Mult. scler\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"542\";s:8:\"\u0000*\u0000epage\";s:3:\"546\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1352-4585\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:24:{i:0;s:12:\"SCHWID, S. R\";i:1;s:8:\"GOELZ, S\";i:2;s:10:\"INGLESE, M\";i:3;s:9:\"KAPOOR, R\";i:4;s:9:\"KAPPOS, L\";i:5;s:11:\"KREITMAN, R\";i:6;s:12:\"LUBLIN, F. D\";i:7;s:7:\"MANN, A\";i:8;s:12:\"MARRIE, R. A\";i:9;s:11:\"O'LOONEY, P\";i:10;s:12:\"POLMAN, C. H\";i:11;s:12:\"ARNOLD, D. L\";i:12;s:12:\"RAVINA, B. M\";i:13;s:14:\"REINGOLD, S. C\";i:14;s:13:\"RICHERT, J. R\";i:15;s:14:\"SANDROCK, A. W\";i:16;s:10:\"WAUBANT, E\";i:17;s:12:\"CUTTER, G. R\";i:18;s:10:\"ARADHYE, S\";i:19;s:12:\"BALCER, L. J\";i:20;s:15:\"CALABRESI, P. A\";i:21;s:11:\"COHEN, J. A\";i:22;s:10:\"COLE, P. E\";i:23;s:11:\"GLANZMAN, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Proof of concept studies for tissue-protective agents in multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Sage Publications\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
